Double-blind, placebo-controlled, randomized mechanistic clinical trial to test an intravenous dose of either ketamine, midazolam, dexmedetomidine, or a placebo (saline) on cigarette smoking behavior, craving, and neural effects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Difference in craving between drug and placebo
Timeframe: 24-hours post infusion
Difference in tobacco withdrawal symptoms
Timeframe: 24-hours post infusion
Difference in cigarette demand
Timeframe: 24-hours post infusion
Number of cigarettes smoked ad lib
Timeframe: 24-hours post infusion